Methods and compositions to inhibit P2X7 receptor expression

Details for Australian Patent Application No. 2005278918 (hide)

Owner Sylentis S.A.U.

Inventors Gonzalez De Buitrago, Gonzalo; Jimenez, Ana I.; Gascon, Irene; Jimenez, Maria C.; Roman, Jose P.; Sesto, Angela

Agent Griffith Hack

Pub. Number AU-B-2005278918

PCT Pub. Number WO2006/024880

Priority 0504057.1 28.02.05 GB; 0419295.1 31.08.04 GB

Filing date 30 August 2005

Wipo publication date 9 March 2006

Acceptance publication date 29 July 2010

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

22 March 2007 PCT application entered the National Phase

  PCT publication WO2006/024880 Priority application(s): WO2006/024880

29 July 2010 Application Accepted

  Published as AU-B-2005278918

25 November 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005278919-Multiparticulates of preferably an opioid, and method of manufacturing using extrusion

2005278914-Apparatus, systems and methods for compensating broadcast sources